BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 37475862)

  • 1. Multi-omics analyses of glucose metabolic reprogramming in colorectal cancer.
    Huang M; Wu Y; Cheng L; Fu L; Yan H; Ru H; Mo X; Yan L; Su Z
    Front Immunol; 2023; 14():1179699. PubMed ID: 37475862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. THBS1 facilitates colorectal liver metastasis through enhancing epithelial-mesenchymal transition.
    Liu X; Xu D; Liu Z; Li Y; Zhang C; Gong Y; Jiang Y; Xing B
    Clin Transl Oncol; 2020 Oct; 22(10):1730-1740. PubMed ID: 32052380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteomics and liquid biopsy characterization of human EMT-related metastasis in colorectal cancer.
    Huang MS; Fu LH; Yan HC; Cheng LY; Ru HM; Mo S; Wei CY; Li DM; Mo XW; Tang WZ; Yan LH
    Front Oncol; 2022; 12():790096. PubMed ID: 36249004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomics and prognosis analysis of epithelial-mesenchymal transition in colorectal cancer patients.
    Zhang Z; Zheng S; Lin Y; Sun J; Ding N; Chen J; Zhong J; Shi L; Xue M
    BMC Cancer; 2020 Nov; 20(1):1135. PubMed ID: 33228590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteogenomic characterization of primary colorectal cancer and metastatic progression identifies proteome-based subtypes and signatures.
    Tanaka A; Ogawa M; Zhou Y; Namba K; Hendrickson RC; Miele MM; Li Z; Klimstra DS; Buckley PG; Gulcher J; Wang JY; Roehrl MHA
    Cell Rep; 2024 Feb; 43(2):113810. PubMed ID: 38377004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incomplete cellular reprogramming of colorectal cancer cells elicits an epithelial/mesenchymal hybrid phenotype.
    Hiew MSY; Cheng HP; Huang CJ; Chong KY; Cheong SK; Choo KB; Kamarul T
    J Biomed Sci; 2018 Jul; 25(1):57. PubMed ID: 30025541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of circulating free DNA in evaluating clinical tumor burden and predicting survival in Chinese metastatic colorectal cancer patients.
    Xu X; Yu Y; Shen M; Liu M; Wu S; Liang L; Huang F; Zhang C; Guo W; Liu T
    BMC Cancer; 2020 Oct; 20(1):1006. PubMed ID: 33066758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Fluorine-18 2-Fluoro-2-Deoxy-D-Glucose Uptake on Preoperative Positron Emission Tomography/Computed Tomography in the Lymph Nodes of Patients with Primary Colorectal Cancer.
    Sasaki K; Kawasaki H; Sato M; Koyama K; Yoshimi F; Nagai H
    Dig Surg; 2017; 34(1):60-67. PubMed ID: 27454870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-200c modulates epithelial-to-mesenchymal transition (EMT) in human colorectal cancer metastasis.
    Hur K; Toiyama Y; Takahashi M; Balaguer F; Nagasaka T; Koike J; Hemmi H; Koi M; Boland CR; Goel A
    Gut; 2013 Sep; 62(9):1315-26. PubMed ID: 22735571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 18F-Fluorodeoxyglucose uptake on positron emission tomography/computed tomography is associated with metastasis and epithelial-mesenchymal transition in hepatocellular carcinoma.
    Lee M; Jeon JY; Neugent ML; Kim JW; Yun M
    Clin Exp Metastasis; 2017 Apr; 34(3-4):251-260. PubMed ID: 28429188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrated proteomic and phosphoproteomic analysis for characterization of colorectal cancer.
    Zhu H; Li Y; Guo J; Feng S; Ge H; Gu C; Wang M; Nie R; Li N; Wang Y; Wang H; Zhong J; Qian X; He G
    J Proteomics; 2023 Mar; 274():104808. PubMed ID: 36596410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective study on diagnostic and prognostic significance of postoperative FDG PET/CT in recurrent colorectal carcinoma patients: comparison with MRI and tumor markers.
    Odalovic S; Stojiljkovic M; Sobic-Saranovic D; Pandurevic S; Brajkovic L; Milosevic I; Grozdic-Milojevic I; Artiko V
    Neoplasma; 2017; 64(6):954-961. PubMed ID: 28895416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Luteolin inhibits colorectal cancer cell epithelial-to-mesenchymal transition by suppressing CREB1 expression revealed by comparative proteomics study.
    Liu Y; Lang T; Jin B; Chen F; Zhang Y; Beuerman RW; Zhou L; Zhang Z
    J Proteomics; 2017 May; 161():1-10. PubMed ID: 28391045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ALDOC- and ENO2- driven glucose metabolism sustains 3D tumor spheroids growth regardless of nutrient environmental conditions: a multi-omics analysis.
    De Vitis C; Battaglia AM; Pallocca M; Santamaria G; Mimmi MC; Sacco A; De Nicola F; Gaspari M; Salvati V; Ascenzi F; Bruschini S; Esposito A; Ricci G; Sperandio E; Massacci A; Prestagiacomo LE; Vecchione A; Ricci A; Sciacchitano S; Salerno G; French D; Aversa I; Cereda C; Fanciulli M; Chiaradonna F; Solito E; Cuda G; Costanzo F; Ciliberto G; Mancini R; Biamonte F
    J Exp Clin Cancer Res; 2023 Mar; 42(1):69. PubMed ID: 36945054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated tumor-to-liver uptake ratio (TLR) from
    Huang J; Huang L; Zhou J; Duan Y; Zhang Z; Wang X; Huang P; Tan S; Hu P; Wang J; Huang M
    Eur J Nucl Med Mol Imaging; 2017 Nov; 44(12):1958-1968. PubMed ID: 28812134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Up-regulation of type I collagen during tumorigenesis of colorectal cancer revealed by quantitative proteomic analysis.
    Zou X; Feng B; Dong T; Yan G; Tan B; Shen H; Huang A; Zhang X; Zhang M; Yang P; Zheng M; Zhang Y
    J Proteomics; 2013 Dec; 94():473-85. PubMed ID: 24332065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 3'-Deoxy-3'-
    Kim JE; Chae SY; Kim JH; Kim HJ; Kim TW; Kim KP; Kim SY; Lee JL; Oh SJ; Kim JS; Ryu JS; Moon DH; Hong YS
    Eur J Nucl Med Mol Imaging; 2019 Jul; 46(8):1713-1722. PubMed ID: 31041456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crosstalk between cancer cells and tumor associated macrophages is required for mesenchymal circulating tumor cell-mediated colorectal cancer metastasis.
    Wei C; Yang C; Wang S; Shi D; Zhang C; Lin X; Liu Q; Dou R; Xiong B
    Mol Cancer; 2019 Mar; 18(1):64. PubMed ID: 30927925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticolorectal Cancer Effects of AUCAN: Effects to Suppress Proliferation, Metastasis, and Invasion of Tumor Cells.
    Xiong LL; Du RL; Chen JJ; Jiang Y; Xue LL; Niu RZ; Chen L; Liu J; Wang TH
    Biomed Res Int; 2020; 2020():9786428. PubMed ID: 33102601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.